ContraVir

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch ContraVir and buy or sell other stocks, options, and ETFs commission-free!

About CTRV

Hepion Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of drug therapy for treatment of chronic liver diseases. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways involved in the progression of liver disease. 

CEO
Robert T. Foster, PhD
CEORobert T. Foster, PhD
Employees
Employees
Headquarters
Edison, New Jersey
HeadquartersEdison, New Jersey
Founded
2013
Founded2013
Employees
Employees

CTRV Key Statistics

Market cap
115.86M
Market cap115.86M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
845.95K
Average volume845.95K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$3.85
52 Week high$3.85
52 Week low
$1.36
52 Week low$1.36
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.